BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 14586055)

  • 1. Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury.
    Eisner MD; Parsons P; Matthay MA; Ware L; Greene K;
    Thorax; 2003 Nov; 58(11):983-8. PubMed ID: 14586055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuromuscular blockade is associated with the attenuation of biomarkers of epithelial and endothelial injury in patients with moderate-to-severe acute respiratory distress syndrome.
    Sottile PD; Albers D; Moss MM
    Crit Care; 2018 Mar; 22(1):63. PubMed ID: 29523157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of surfactant protein D and KL-6 for evaluation of lung injury in critically ill mechanically ventilated patients.
    Determann RM; Royakkers AA; Haitsma JJ; Zhang H; Slutsky AS; Ranieri VM; Schultz MJ
    BMC Pulm Med; 2010 Feb; 10():6. PubMed ID: 20158912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma surfactant protein-D as a diagnostic biomarker for acute respiratory distress syndrome: validation in US and Korean cohorts.
    Park J; Pabon M; Choi AMK; Siempos II; Fredenburgh LE; Baron RM; Jeon K; Chung CR; Yang JH; Park CM; Suh GY
    BMC Pulm Med; 2017 Dec; 17(1):204. PubMed ID: 29246207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The clinical effect of airway pressure release ventilation for acute lung injury/acute respiratory distress syndrome].
    Song S; Tian H; Yang X; Hu Z
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Jan; 28(1):15-21. PubMed ID: 26805529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surfactant Protein D Is Associated With Severe Pediatric ARDS, Prolonged Ventilation, and Death in Children With Acute Respiratory Failure.
    Dahmer MK; Flori H; Sapru A; Kohne J; Weeks HM; Curley MAQ; Matthay MA; Quasney MW;
    Chest; 2020 Sep; 158(3):1027-1035. PubMed ID: 32275979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of surfactant proteins A and D in patients with acute lung injury.
    Cheng IW; Ware LB; Greene KE; Nuckton TJ; Eisner MD; Matthay MA
    Crit Care Med; 2003 Jan; 31(1):20-7. PubMed ID: 12544988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury.
    Parsons PE; Eisner MD; Thompson BT; Matthay MA; Ancukiewicz M; Bernard GR; Wheeler AP;
    Crit Care Med; 2005 Jan; 33(1):1-6; discussion 230-2. PubMed ID: 15644641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of low tidal volume ventilation in patients with different clinical risk factors for acute lung injury and the acute respiratory distress syndrome.
    Eisner MD; Thompson T; Hudson LD; Luce JM; Hayden D; Schoenfeld D; Matthay MA;
    Am J Respir Crit Care Med; 2001 Jul; 164(2):231-6. PubMed ID: 11463593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The application of individualized ventilation strategies in acute respiratory distress syndrome].
    Long Y; Liu DW; Zhou X; Liu HZ; Guo ZJ; Huang H; Wang XT; Rui X; Cui N
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Aug; 29(8):549-53. PubMed ID: 17074270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surfactant protein A and D (SP-A, AP-D) levels in patients with septic ARDS.
    Endo S; Sato N; Nakae H; Yamada Y; Makabe H; Abe H; Imai S; Wakabayashi G; Inada K; Sato S
    Res Commun Mol Pathol Pharmacol; 2002; 111(5-6):245-51. PubMed ID: 15244040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma sRAGE is independently associated with increased mortality in ARDS: a meta-analysis of individual patient data.
    Jabaudon M; Blondonnet R; Pereira B; Cartin-Ceba R; Lichtenstern C; Mauri T; Determann RM; Drabek T; Hubmayr RD; Gajic O; Uhle F; Coppadoro A; Pesenti A; Schultz MJ; Ranieri MV; Brodska H; Mrozek S; Sapin V; Matthay MA; Constantin JM; Calfee CS
    Intensive Care Med; 2018 Sep; 44(9):1388-1399. PubMed ID: 30051136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of type II secretory phospholipase A
    Ishibe Y; Shibata S; Takahashi G; Suzuki Y; Inoue Y; Endo S
    J Clin Apher; 2017 Oct; 32(5):302-310. PubMed ID: 27623356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS.
    Greene KE; Wright JR; Steinberg KP; Ruzinski JT; Caldwell E; Wong WB; Hull W; Whitsett JA; Akino T; Kuroki Y; Nagae H; Hudson LD; Martin TR
    Am J Respir Crit Care Med; 1999 Dec; 160(6):1843-50. PubMed ID: 10588595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PReVENT--protective ventilation in patients without ARDS at start of ventilation: study protocol for a randomized controlled trial.
    Simonis FD; Binnekade JM; Braber A; Gelissen HP; Heidt J; Horn J; Innemee G; de Jonge E; Juffermans NP; Spronk PE; Steuten LM; Tuinman PR; Vriends M; de Vreede G; de Wilde RB; Serpa Neto A; Gama de Abreu M; Pelosi P; Schultz MJ
    Trials; 2015 May; 16():226. PubMed ID: 26003545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma CC16 levels are associated with development of ALI/ARDS in patients with ventilator-associated pneumonia: a retrospective observational study.
    Determann RM; Millo JL; Waddy S; Lutter R; Garrard CS; Schultz MJ
    BMC Pulm Med; 2009 Dec; 9():49. PubMed ID: 19958527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarker profiles of coagulopathy and alveolar epithelial injury in acute respiratory distress syndrome with idiopathic/immune-related disease or common direct risk factors.
    Koyama K; Katayama S; Tonai K; Shima J; Koinuma T; Nunomiya S
    Crit Care; 2019 Aug; 23(1):283. PubMed ID: 31426849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Research of the biomarkers in pulmonary and extrapulmonary acute respiratory distress syndrome].
    Yang Q; Li ZQ; Lan HB; Xiong SS; Wang SS; Yan CS
    Zhonghua Yi Xue Za Zhi; 2017 Jul; 97(26):2023-2027. PubMed ID: 28763872
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury.
    Calfee CS; Ware LB; Eisner MD; Parsons PE; Thompson BT; Wickersham N; Matthay MA;
    Thorax; 2008 Dec; 63(12):1083-9. PubMed ID: 18566109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome.
    Brower RG; Lanken PN; MacIntyre N; Matthay MA; Morris A; Ancukiewicz M; Schoenfeld D; Thompson BT;
    N Engl J Med; 2004 Jul; 351(4):327-36. PubMed ID: 15269312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.